Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 52% ± 19% | |
lung | 16 studies | 30% ± 11% | |
peripheral blood | 14 studies | 29% ± 14% | |
eye | 10 studies | 41% ± 15% | |
kidney | 7 studies | 28% ± 9% | |
intestine | 7 studies | 25% ± 11% | |
heart | 5 studies | 34% ± 9% | |
liver | 5 studies | 40% ± 15% | |
bone marrow | 4 studies | 33% ± 14% | |
lymph node | 4 studies | 25% ± 8% | |
adipose | 4 studies | 45% ± 18% | |
placenta | 3 studies | 22% ± 6% | |
uterus | 3 studies | 42% ± 16% | |
breast | 3 studies | 28% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4524.66 | 1445 / 1445 | 100% | 30.94 | 183 / 183 |
brain | 100% | 4855.50 | 2638 / 2642 | 99% | 23.55 | 701 / 705 |
breast | 100% | 5612.24 | 459 / 459 | 99% | 29.80 | 1108 / 1118 |
lung | 100% | 4658.46 | 578 / 578 | 99% | 18.92 | 1138 / 1155 |
ovary | 100% | 7518.38 | 180 / 180 | 98% | 16.19 | 423 / 430 |
intestine | 100% | 5290.51 | 966 / 966 | 98% | 15.53 | 518 / 527 |
thymus | 100% | 5918.39 | 653 / 653 | 98% | 17.30 | 593 / 605 |
pancreas | 99% | 2420.28 | 326 / 328 | 98% | 14.47 | 175 / 178 |
bladder | 100% | 4719.00 | 21 / 21 | 98% | 15.28 | 492 / 504 |
prostate | 100% | 5059.66 | 245 / 245 | 98% | 18.31 | 490 / 502 |
stomach | 100% | 3586.53 | 359 / 359 | 98% | 19.13 | 279 / 286 |
uterus | 100% | 7276.02 | 170 / 170 | 96% | 15.01 | 442 / 459 |
skin | 100% | 6243.18 | 1809 / 1809 | 95% | 20.21 | 450 / 472 |
kidney | 100% | 3606.90 | 89 / 89 | 93% | 15.11 | 836 / 901 |
adrenal gland | 100% | 4248.13 | 258 / 258 | 87% | 11.41 | 200 / 230 |
liver | 98% | 1693.53 | 222 / 226 | 67% | 6.56 | 271 / 406 |
adipose | 100% | 5192.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4999.20 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.58 | 29 / 29 |
muscle | 100% | 3252.32 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4863.85 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.89 | 1 / 1 |
heart | 96% | 2643.03 | 825 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 14.93 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 89% | 12.84 | 71 / 80 |
peripheral blood | 84% | 3267.92 | 783 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001892 | Biological process | embryonic placenta development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0007492 | Biological process | endoderm development |
GO_1990090 | Biological process | cellular response to nerve growth factor stimulus |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0007420 | Biological process | brain development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0005737 | Cellular component | cytoplasm |
GO_0044297 | Cellular component | cell body |
GO_1904949 | Cellular component | ATPase complex |
GO_0016589 | Cellular component | NURF complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
GO_0005515 | Molecular function | protein binding |
Gene name | BPTF |
Protein name | BPTF protein Bromodomain PHD finger transcription factor Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen) |
Synonyms | FALZ FAC1 |
Description | FUNCTION: Regulatory subunit of the ATP-dependent NURF-1 and NURF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair . The NURF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the NURF-5 ISWI chromatin remodeling complex . Within the NURF-1 ISWI chromatin-remodeling complex, binds to the promoters of En1 and En2 to positively regulate their expression and promote brain development . Histone-binding protein which binds to H3 tails trimethylated on 'Lys-4' (H3K4me3), which mark transcription start sites of active genes . Binds to histone H3 tails dimethylated on 'Lys-4' (H3K4Me2) to a lesser extent . May also regulate transcription through direct binding to DNA or transcription factors . . |
Accessions | J3KSK9 E7ETD6 ENST00000321892.8 [Q12830-1] F5H176 F5GXF5 ENST00000581258.5 J3KSY0 ENST00000424123.7 ENST00000544491.2 ENST00000644067.1 ENST00000544778.6 ENST00000577837.1 A0A2R8Y7Q1 ENST00000582467.2 ENST00000580465.5 Q12830 J3QQK4 E9PE19 Q86TN2 ENST00000583990.1 ENST00000306378.11 [Q12830-2] J3QLW4 J3QQQ8 ENST00000342579.8 |